Biocon Ltd. — Investor Relations & Filings
Biocon Ltd. is a global biopharmaceutical company focused on developing innovative therapies for chronic conditions such as diabetes, oncology, and autoimmune diseases. The company specializes in the research, development, and manufacture of high-quality biosimilars, generic active pharmaceutical ingredients (APIs), and novel biologics. Its portfolio includes recombinant human insulin, insulin analogs, and monoclonal antibodies. Biocon leverages an integrated business model encompassing advanced research and development, large-scale manufacturing, and global commercialization. By prioritizing affordable innovation, the company aims to enhance access to life-saving treatments across international markets, including the United States, Europe, and emerging economies. Its technical expertise in microbial fermentation and complex protein engineering supports a robust pipeline of complex therapeutics designed to address unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Monitoring Agency Report | 2026-05-07 | English | |
| Record Date | 2026-05-07 | English | |
| Press Release | 2026-05-07 | English | |
| Outcome of Board Meeting | 2026-05-07 | English | |
| Outcome of Board Meeting | 2026-05-07 | English | |
| Outcome of Board Meeting | 2026-05-07 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 43390572 | Monitoring Agency Report | 2026-05-07 | English | ||
| 43348518 | Record Date | 2026-05-07 | English | ||
| 43348530 | Press Release | 2026-05-07 | English | ||
| 43348544 | Outcome of Board Meeting | 2026-05-07 | English | ||
| 43348559 | Outcome of Board Meeting | 2026-05-07 | English | ||
| 43348574 | Outcome of Board Meeting | 2026-05-07 | English | ||
| 43348589 | Change in Auditors | 2026-05-07 | English | ||
| 43348605 | Dividend | 2026-05-07 | English | ||
| 43348619 | Outcome of Board Meeting | 2026-05-07 | English | ||
| 42162648 | News Verification | 2026-05-06 | English | ||
| 42162683 | Rumour Verification - Regulation 30(11) | 2026-05-06 | English | ||
| 42271037 | Board Meeting — Board Meeting Intimation | 2026-05-04 | English | ||
| 42271069 | Board Meeting — Fund Raising | 2026-05-04 | English | ||
| 42181205 | Updates | 2026-04-30 | English | ||
| 42199704 | Copy of Newspaper Publication | 2026-04-28 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ArriVent BioPharma, Inc.
Clinical-stage biopharma developing oncology drugs for diff…
|
AVBP | US | Manufacturing |
|
ARROWHEAD PHARMACEUTICALS, INC.
Biotechnology company developing RNAi therapies to treat in…
|
ARWR | US | Manufacturing |
|
ARS Pharmaceuticals, Inc.
Develops and commercializes needle-free products for admini…
|
SPRY | US | Manufacturing |
|
ARTELO BIOSCIENCES, INC.
Clinical-stage biopharma developing therapeutics by modulat…
|
ARTL | US | Manufacturing |
|
Arura Pharma Inc
Diversified manufacturer and distributor in consumer goods …
|
— | CA | Manufacturing |
|
Ascelia Pharma
Biotechnology company developing and commercializing novel …
|
ACE | SE | Manufacturing |
|
Ascendis Pharma A/S
Biopharmaceutical firm using its prodrug technology to trea…
|
ASND | DK | Manufacturing |
|
Ascentage Pharma Group International
Integrated biopharma developing novel small molecule therap…
|
6855 | HK | Manufacturing |
|
ASCENTAGE PHARMA GROUP INTERNATIONAL
A clinical-stage biopharma developing novel therapies for c…
|
AAPG | US | Manufacturing |
|
Ascletis Pharma Inc.
R&D driven biotech developing best-in-class therapeutics, p…
|
1672 | KY | Manufacturing |
Biocon Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61176/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61176 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61176 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61176 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61176}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biocon Ltd. (id: 61176)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.